PRTN3 and rheumatoid arthritis: To identify potential-binding partners of VDGs in solution, we generated ACPA IgG mAbs expressing VDGs from an RA patient-derived BCR sequence (from here on referred to as 3F3 wild type (WT); Kissel et al. 2020, 2022; Supplementary Fig. 2a).